[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Michael Kirban, Executive Chairman and Director of Vita Coco Company, Inc. (COCO), reported transactions on 09/22/2025. He sold 20,000 shares of common stock pursuant to a Rule 10b5-1 trading plan at a weighted average price of $41.535 per share. The Form 4 shows he beneficially owns 1,529,049 shares indirectly through the Michael Kirban 2010 Trust and additional holdings reflected as direct and indirect positions. The filing also lists multiple outstanding non-qualified stock options with exercise prices from $10.178 to $32.78 and varying vesting or exercisability dates.

Insights

Financial Analyst

TL;DR: Insider sold a small block under a Rule 10b5-1 plan; sizeable indirect holdings and multiple exercisable/options remain.

The Form 4 discloses a 20,000-share disposition executed under a Rule 10b5-1 plan at a weighted average of $41.535. The reporting person retains material indirect ownership of 1,529,049 shares via the Michael Kirban 2010 Trust and holds numerous stock options across maturities and strike prices, several of which are fully vested and exercisable. From an equity-capital perspective, the filing documents routine insider liquidity rather than a change in control or debt-equity structure.

Corporate Governance Expert

TL;DR: Disclosure is complete and notes use of an affirmative-defense trading plan; no governance actions or departures reported.

The filer explicitly states the sale was made pursuant to a Rule 10b5-1 trading plan and provides weighted-average pricing ranges, which supports procedural transparency. The Form 4 identifies the reporting person as both Executive Chairman and a director and documents indirect ownership via trusts and multiple option grants with vesting schedules. There are no disclosed resignations, new appointments, or governance events in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kirban Michael

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
09/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/22/2025		S(1)		20,000	D	$41.535(2)	1,529,049	I	by M. Kirban 2010(3)
Common Stock								127,629	D
Common Stock								615,681	I	by M. Kirban Revoc(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178							(5)	12/16/2029	Common Stock	546,000		546,000	D
Non-Qualified Stock Option (right to buy)	$10.178							(6)	01/11/2031	Common Stock	40,950		40,950	D
Non-Qualified Stock Option (right to buy)	$15							(7)	10/21/2031	Common Stock	298,507		298,507	D
Non-Qualified Stock Option (right to buy)	$16.91							(8)	03/10/2033	Common Stock	46,875		46,875	D
Non-Qualified Stock Option (right to buy)	$26.18							(9)	03/04/2034	Common Stock	62,743		62,743	D
Non-Qualified Stock Option (right to buy)	$32.78							(10)	03/03/2035	Common Stock	70,715		70,715	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.50 to $41.60, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. These shares are held by the Michael Kirban 2010 Trust.

4. These shares are held by the Michael Kirban Revocable Trust.

5. The stock option is fully vested and currently exercisable.

6. The stock option is fully vested and currently exercisable.

7. The stock option vests in four equal annual installments beginning on November 27, 2022.

8. The stock option vests in four equal annual installments beginning on March 10, 2024.

9. The stock option vests in four equal annual installments beginning on March 4, 2025.

10. The Stock Option vests in four equal annual installments beginning in March 3, 2026.

	By: Alison Klein, Attorney-in-Fact For: Michael Kirban	09/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Michael Kirban report on Form 4 for COCO?

The Form 4 reports a sale of 20,000 shares on 09/22/2025 under a Rule 10b5-1 plan at a weighted average price of $41.535 and details existing beneficial holdings and option grants.

How many shares does Michael Kirban beneficially own after the reported transaction?

The filing states he beneficially owns 1,529,049 shares indirectly through the Michael Kirban 2010 Trust.

Were the share sales part of a pre-established trading plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan.

What option holdings does the Form 4 disclose for Michael Kirban?

The Form 4 discloses multiple non-qualified stock options with exercise prices of $10.178, $15, $16.91, $26.18, $32.78 covering various share amounts and vesting/exercise dates; several are fully vested and exercisable.

Does the filing report any changes in Michael Kirban’s officer or director status?

No. The filing continues to identify him as Executive Chairman and a Director; no changes in roles are reported.